These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 17320377)

  • 1. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.
    Monzani E; Facchetti F; Galmozzi E; Corsini E; Benetti A; Cavazzin C; Gritti A; Piccinini A; Porro D; Santinami M; Invernici G; Parati E; Alessandri G; La Porta CA
    Eur J Cancer; 2007 Mar; 43(5):935-46. PubMed ID: 17320377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
    Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
    Lai CY; Schwartz BE; Hsu MY
    Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential characteristics of CD133(+) and CD133 (-) Jurkat cells.
    Anbarlou A; Atashi A; Soleimani M; AkhavanRahnama M; Bohloli M; Mossahebi-Mohammadi M
    In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):556-61. PubMed ID: 25630537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4.
    Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH
    Tumour Biol; 2009; 30(5-6):300-9. PubMed ID: 19940551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
    Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
    Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
    Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of expression of cancer stem cell-related markers in orbital adenoid cystic carcinoma].
    Lin TT; Zhu LM; He YJ; Zhang H
    Zhonghua Yan Ke Za Zhi; 2011 Aug; 47(8):703-8. PubMed ID: 22169609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury.
    Nichols JE; Niles JA; DeWitt D; Prough D; Parsley M; Vega S; Cantu A; Lee E; Cortiella J
    Stem Cell Res Ther; 2013 Jan; 4(1):3. PubMed ID: 23290300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
    Sharma BK; Manglik V; O'Connell M; Weeraratna A; McCarron EC; Broussard JN; Divito KA; Simbulan-Rosenthal CM; Rosenthal DS; Zapas JL
    Int J Oncol; 2012 Nov; 41(5):1570-6. PubMed ID: 22922842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors.
    Kumamoto H; Ohki K
    J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133+ renal progenitor cells contribute to tumor angiogenesis.
    Bruno S; Bussolati B; Grange C; Collino F; Graziano ME; Ferrando U; Camussi G
    Am J Pathol; 2006 Dec; 169(6):2223-35. PubMed ID: 17148683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.